1 / 42

Lecture 2 Epidemiology of meninigitis

Lecture 2 Epidemiology of meninigitis. Dr. Abdelraouf A. Elmanama Islamic University-Gaza Medical Technology Department. Lecture outlines. Epidemiology of menigitis Risk factors of meningitis Pathogens details Vaccines Prophylactics Introduction to Lab diagnosis. Epidemiology.

yauvani
Download Presentation

Lecture 2 Epidemiology of meninigitis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Lecture 2Epidemiology of meninigitis Dr. Abdelraouf A. Elmanama Islamic University-Gaza Medical Technology Department

  2. Lecture outlines • Epidemiology of menigitis • Risk factors of meningitis • Pathogens details • Vaccines • Prophylactics • Introduction to Lab diagnosis

  3. Epidemiology • Incidence is between 3-5 per 100,000 • More than 2,000 deaths annually in the U.S. • Relative frequency of bacterial species varies with age.

  4. Epidemiology • Neonates(< 1 Month) • Gm (-) bacilli 50-60% • Grp B Strep 20-40% • Listeria sp. 2-10% • H. influenza 0-3% • S. pneumo 0-5%

  5. Epidemiology • Children (1 month to 15 years) • H. influenzae 40-60% • Declining dramatically in many geographic regions • N. meningitidis 25-40% • S. pneumo 10-20%

  6. Epidemiology • Adults (> 15 years) • S. pneumo 30-50% • N. Meningitidis 10-35% • Major cause in epidemics • Gm (-) Bacilli 1-10% • Elderly • S. aureus 5-15% • H. influenzae 1-3% • >60 include Listeria, E. coli, Pseudomonas

  7. Risk factors • Age. • Most cases of viral meningitis occur in children younger than age 5. • In the past, bacterial meningitis also usually affected young children. • But since the mid-1980s, as a result of the protection offered by current childhood vaccines, the median age at which bacterial meningitis is diagnosed has shifted from 15 months to 25 years.

  8. Risk factors • Living in a community setting. • College students living in dormitories, personnel on military bases, and • children in boarding schools and • child care facilities • are at increased risk of meningococcal meningitis, probably because infectious diseases tend to spread quickly wherever large groups of people congregate.

  9. Risk factors • Pregnancy.If you're pregnant, you're at increased of contracting listeriosis — an infection caused by listeria bacteria, which may also cause meningitis. If you have listeriosis, your unborn baby is at risk, too.

  10. Risk factors • Working with animals.People who work with domestic animals, including dairy farmers and ranchers, have a higher risk of contracting listeria, which can lead to meningitis.

  11. Risk factors • Compromised immune system.Factors that may compromise your immune system — • including AIDS, diabetes and use of immunosuppressant drugs — also make you more susceptible to meningitis. • Removal of your spleen, an important part of your immune system, also may increase your risk.

  12. Risk factors • Alcoholism • Autoimmune disorders (e.g., lupus( • Immunosuppressive drugs (e.g., corticosteroids, chemotherapies( • Intravenous drug abuse • cancer, diabetes • Smoking • Head injuries and brain surgery also put patients at risk for meningitis

  13. Meningitis Pathogens • L. monocytogenes

  14. Morphology and general characteristics • Small G+ B which may appear pleomorphic • Nonsporing and nonencapsulated • Motile by peritrichous flagella at RT (umbrella motility) and polar flagella at 370 C.

  15. Listeria umbrella motility at RT

  16. L. monocytogenes • Grows well on ordinary lab media and on CBA it produces beta hemolysis and colonies resemble Strep. pyogenes colonies • Aerobic to microaerophilic • Biochemistry • Catalase + • TSI= A/A, H2S- • Esculin hydrolysis +

  17. Typical Listeria rxn Esculin hydrolysis Catalase; bubbles production

  18. Listeria on BA

  19. CAMP + • Grows in 6.5% NaCl • Antigenic structure • Four major serogroups (1-4) based on O antigen • Serotypes based on H antigen • Type 1b accounts for most infections; • May also find 1a and 4b in significant amounts

  20. Listeria pathogenesis

  21. Listeria pathogenesis • Pregnancy renders an individual more susceptible to the infection, though the effect on the mom is usually minimal. It can be devastating for the fetus or newborn. • In neonates, the disease occurs in two forms • Early onset – the infant is infected transplacentally with the production of septicemia and granulomatous foci in many organs. This may result in abortion, stillbirth, premature delivery, or death soon after birth. The baby is born with cardio and respiratory distress, vomiting, diarrhea, meningitis, hepatosplenomegaly, and skin lesions. The fatality rate is 70-90% in untreated cases.

  22. Listeria pathogenesis • Late onset – the infant is infected from the genital tract during delivery. Infection usually begins 1-4 weeks after birth and is manifested as meningitis with a high fatality rate. • Antimicrobic susceptibility/treatment • Prognosis is poor in neonates so infected moms should be treated as soon as disease is diagnosed • Penicillin is the drug of choice. Can also use erhthromycin or tetracycline.

  23. Streptococcuspneumoniae

  24. Morphology and general characteristics MORPHOLOGY • Gram-positive cocci – lancet / bullet shape • Diplococci (arranged in pairs) – the adjacent ends of pair are rounded while other ends are pointed • Virulent strains are capsulated CULTURAL CHARACTERISTICS • Facultative anaerobic; 5-10% CO2 enhance growth • Grow on enriched media (blood & chocolate agar)

  25. PATHOGENICITY FACTORS Capsule • Antiphagocytic • S. pneumoniae > 80 serotypes on the basis of antigenic differences in polysaccharide capsule Toxins and extracellular enzymes • IgA protease : help in colonization in resp tract • Pneumolysin - properties like Streptolysin • Neuroaminidase – spreading factor

  26. 10-30% of normal people carry one or • more serotypes in throat • Pneumococcal pneumonia • High grade fever, cough, rusty sputum (reddish) • Difficult breathing, chest pain • Meningitis (all age groups) • Sinusitis • Otitis media

  27. TREATMENT • Penicillins – drugs of choice • Penicillin-resistant strains are treated with erythromycin • PREVENTION • Vaccination with polyvalent vaccine prepared from polysaccharide capsules of 23 serotypes • Given to susceptible groups – elderly patients, diabetics, chronic pulmonary disease, immunocompromised

  28. Susceptibility  • Children< 2, adults over 65, • Splenectomy, • Chronic lymphatic leukemia, Multiple myeloma, • Sickle cell anemia, • Postinfluenza, • COPD, smokers  • Clinical Features • Rusty sputum Single shaking chill    • Associated Sites of Infection • Bacteremia 25-50% • Pleural effusions, arthritis, meningitis, endocarditis Sinusitis    • Sputum Gram Stain  •  Encapsulated lancet-shaped Gram-positive diplococci or short chains

  29. Laboratory diagnosis ofS. pneumoniae

  30. CULTURAL CHARACTERISTICS • Facultative anaerobic; 5-10% CO2 enhance growth • Grow on enriched media (blood & chocolate agar) • Alpha-haemolytic colonies on blood agar

  31. Optochin

  32. Bile solubility

  33. Quellung reaction

  34. TREATMENT • Penicillins – drugs of choice • Penicillin-resistant strains have been reported due to • alteration in PBP • Penicillin-resistant strains are treated with erythromycin • PREVENTION • Vaccination with polyvalent vaccine prepared from polysaccharide capsules of 23 serotypes. • Given to susceptible groups – elderly patients, diabetics, chronic pulmonary disease, immunocompromised.

  35. HAEMOPHILUS • IMPORTANT SPECIES • H. influenzae • H. ducreyi • H. influenzae • Gram-negative coccobacilli • Some strains capsulated • Six serotypes (a-f) on the basis of capsular antigens • Type b (Hib)- the main pathogen • Non-capsulated strains are present in nasopharynx of 25-80% of healthy people • Hib in 2-5% of healthy people

  36. Haemophilus influenzae Growth Requirements • Growth improved in CO2 • Grow on enriched media (chocolate agar) • Needs X factor (haematin) & V factor Nicotinamide Adenine Dinuclotide (NAD) • Both are present in RBCs and are released on heating (chocolate agar) • V- factor can be produced by yeast & S. aureus • H. influenzae can grow on blood agar in vicinity of colony of S. aureus - satellitism

  37. H. influenzae colonies S. aureus Blood agar plate SATELLITISM BY H. INFLUENZAE

  38. PATHOGENESIS Type b (capsulated) • Is primary pathogen • IgA protease - degrades secretory IgA and help attachment to respiratory mucosa • Capsule - antiphagocytic • Endotoxins

  39. Gram negative bacilliEnterobacteriacae and Others • MacConkey agar is good for almost all gram negative (there are few exceptions) • Oxidase test for preliminary differentiation • TSIA for initial identification • API 20 E is for species identification

  40. Oxidase test TSIA

  41. API 20 E

  42. API 20 E Flash Thank you

More Related